GLP-1s are the only peptides clinically proven to help with weight loss
Bazzato, G., Mezzina, C., Ciman, M., and Guarnieri, G
Biochem Biophys Res Commun 2018;505:523-9.ArticlePubMed 63
However, anticoagulant therapy (low molecular weight heparin) produced better prognoses in patients with severe COVID-19 at high thromboembolic risk, such as those with elevated D-dimer levels 161
Inclinical trials for GLP-1s, 3% of adults reported hair loss compared to 1% taking a placebo
Recent safety reviews have examined whether semaglutide medicines, including Wegovy, may be associated with non-arteritic anterior ischemic optic neuropathy, or NAION